PARINGENIX INC has a total of 17 patent applications. Its first patent ever was published in 1997. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, macromolecular chemistry and polymers and medical technology are ASDERA LLC, YEDGAR SAUL and NANOCARE TECHNOLOGIES INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | Australia | 2 | |
#4 | Canada | 2 | |
#5 | EPO (European Patent Office) | 2 | |
#6 | China | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Macromolecular chemistry and polymers | |
#3 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Polysaccharides | |
#4 | Macromolecular compounds compositions | |
#5 | Electrotherapy |
# | Name | Total Patents |
---|---|---|
#1 | Kennedy Thomas P | 7 |
#2 | Kennedy Thomas Preston | 5 |
#3 | Marcus Stephen | 4 |
#4 | Walenga Jeanine M | 4 |
#5 | Krauel Krystin | 1 |
#6 | Greinacher Andreas | 1 |
Publication | Filing date | Title |
---|---|---|
WO2013016181A1 | Compositions and methods for anti-coagulation | |
WO2012106379A1 | Sensitization of cancer cells to treatment | |
CA2678587A1 | O-desulfated heparins treating acute exacerbations of chronic obstructive pulmonary disease | |
US2007123489A1 | Method and medicament for sulfated polysaccharide treatment of heparin-induced thrombocytopenia (HIT) syndrome | |
US2006040896A1 | Method and medicament for anticoagulation using a sulfated polysaccharide with enhanced anti-inflammatory activity | |
US2005282775A1 | Method and medicament for sulfated polysaccharide treatment of inflammation without inducing platelet activation and heparin-induced thrombocytopenia syndrome | |
EP0918461A1 | Methods of treating asthma with o-desulfated heparin |